Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 6/2015

01-06-2015 | Original Article

Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer

Comparative analysis of inflammation-based prognostic scoring systems

Authors: Edgar Selzer, MD, Anja Grah, Gregor Heiduschka, MD, Gabriela Kornek, MD, Dietmar Thurnher, MD

Published in: Strahlentherapie und Onkologie | Issue 6/2015

Login to get access

Abstract

Introduction

Inflammation-based scoring systems have potential value in evaluating the prognosis of cancer patients; however, detailed comparative analyses in well-characterized head and neck cancer patient collectives are missing.

Methods

We analyzed overall survival (OS) in locally advanced head and neck cancer patients who were treated with curative intent by primary radiotherapy (RT) alone, by RT in combination with cetuximab (RIT) or with cisplatin (RCHT), and by primary surgery followed by postoperative radiotherapy (PORT). The primary RT collective (N = 170) was analyzed separately from the surgery plus RT group (N = 148). OS was estimated using the Kaplan–Meyer method. Cox proportional-hazard regression models were applied to compare the risk of death among patients stratified according to risk factors and the inflammation-based Glasgow Prognostic Score (GPS), the modified GPS (mGPS), the neutrophil–lymphocyte ratio (NLR), the platelet–lymphocyte ratio (PLR), and the prognostic index (PI).

Results

A prognostic relevance of the scoring systems for OS was observed in the primarily irradiated, but not in the PORT collective. OS was 35.5, 18.8, and 15.4 months, respectively, according to GPS 0, 1, and 2. OS according to mGPS 0–2 was identical. The PLR scoring system was not of prognostic relevance, while OS was 27.3 months in the NLR 0 group and 17.3 months in the NLR 1 group. OS was 35.5 months in PI 0, 16.1 months in PI 1, and 22.6 months in PI 2.

Conclusion

GPS/mGPS scoring systems are able to discriminate between three risk groups in primarily, but not postoperatively irradiated locally advanced head and neck cancer patients.
Literature
1.
An X, Ding PR, Wang FH, Jiang WQ, Li YH (2011) Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 32:317–324CrossRefPubMed
2.
3.
Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, Habeshy A, Picon A, Bloom S (2013) Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 30:432CrossRefPubMed
4.
Azab B, Shariff MA, Bachir R, Nabagiez JP, McGinn JT Jr (2013) Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy. J Cardiothorac Surg 8:193CrossRefPubMedCentralPubMed
5.
6.
Colotta F, Allavena P, Sica A et al (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 7:1073–1081CrossRef
7.
8.
Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-Ad V, Pribitkin E, Tuluc M (2014) Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol 41:217–234CrossRefPubMed
9.
Fang HY, Huang XY, Chien HT, Chang JT, Liao CT, Huang JJ, Wei FC, Wang HM, Chen IH, Kang CJ, Huang SF (2013) Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope 123:2690–2699CrossRefPubMed
10.
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small cell lung cancer. Br J Cancer 89:1028–1030CrossRefPubMedCentralPubMed
11.
Gabay C, Kuschner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:1376CrossRef
12.
Grimm M, Lazariotou M (2012) Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma. Med Oncol 29:1435–47
13.
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674 (Review)CrossRefPubMed
14.
Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309–322 (Review)CrossRefPubMed
15.
He JR, Shen GP, Ren ZF, Qin H, Cui C, Zhang Y et al (2012) Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 34:1769–1776CrossRefPubMed
16.
Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R (2009) Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 45:912–914CrossRefPubMed
17.
McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition based management of patients with cancer. Proc Nutr Soc 67:257–262CrossRefPubMed
18.
McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534–540 (Review)CrossRefPubMed
19.
Millrud CR, Månsson Kvarnhammar A, Uddman R, Björnsson S, Riesbeck K, Cardell LO (2012) The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 7:e51120CrossRefPubMedCentralPubMed
20.
Heiduschka G, Grah A, Oberndorfer F, Kadletz L, Altorjai G, Kornek G, Wrba F, Thurnher D, Selzer E (2014). Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy. Strahlenther Onkol. 2014 Sep 25. [Epub ahead of print].
21.
Heiduschka G, Grah A, Oberndorfer F, Seemann R, Kranz A, Kornek G, Wrba F, Thurnher D, Selzer E (2014). Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab. Strahlenther Onkol 190:832–8.
22.
Perisanidis C, Kornek G, Pöschl PW, Holzinger D, Pirklbauer K, Schopper C, Ewers R (2013) High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 30:334CrossRefPubMed
23.
Proctor MJ, Talwar D, Balmar SM, O’Reilly DS, Foulis AK, Horgan PG, Morrison DS, McMillan DC (2010) The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 103:870–876CrossRefPubMedCentralPubMed
24.
Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47:2633–2641CrossRefPubMed
25.
Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE, Thorns C (2013) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626–632CrossRef
26.
Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149–163 (Review)CrossRefPubMed
27.
Rutkowski T, Wygoda A, Składowski K, Hejduk B, Rutkowski R, Kołosza Z, Maciejewski B (2013) Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer. Strahlenther Onkol 189:861–866CrossRefPubMed
28.
Sadat F, Wienke A, Dunst J, Kuhnt T (2012) Survival of patients with head and neck cancer. Impact of physical status and comorbidities. Strahlenther Onkol 188:62–70CrossRefPubMed
29.
Stockmann C, Schadendorf D, Klose R, Helfrich I (2014) The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol 4:69 (Review)CrossRefPubMedCentralPubMed
30.
Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119–150CrossRefPubMed
Metadata
Title
Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer
Comparative analysis of inflammation-based prognostic scoring systems
Authors
Edgar Selzer, MD
Anja Grah
Gregor Heiduschka, MD
Gabriela Kornek, MD
Dietmar Thurnher, MD
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 6/2015
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0803-1

Other articles of this Issue 6/2015

Strahlentherapie und Onkologie 6/2015 Go to the issue

Original Article

Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines

Literatur kommentiert

Schutz des Gedächtnisses durch konformale Aussparung des hippocampalen neuronalen Stammzellenkompartments während der Ganzhirnbestahlung von Hirnmetastasen?

Original Article

Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer

Original Article

Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy

Original Article

Expression of transforming growth factor beta 1-related signaling proteins in irradiated vessels

Literatur kommentiert

Radiotherapie auch beim DCIS mit günstiger Risikokonstellation?